Faculty of Engineering and Natural Sciences, Sabanci University, Istanbul, TurkeyBioprinting; Biomaterials; Tissue/organ printing; Additive manufacturing; 4D Printing
Prof. Dr. Bahattin Koç is the Director of SU IMC and Professor of Manufacturing and Industrial Engineering at the Sabancı University. He received his Ph.D. and M.S. degrees in Industrial/Manufacturing Engineering from North Carolina State University in 2001 and 1997 respectively and his B.S. degree in Industrial Engineering from Istanbul Technical University, Istanbul, Turkey in 1993. He was an Associate Professor (Tenured) of Industrial and Systems Engineering at the University at Buffalo (UB) before joining to Sabancı University in 2010.
His research interests include additive manufacturing, heterogeneous object modelling and manufacturing, computational geometry for design and manufacturing, nano/micro-scale manufacturing, three dimensional (3D) Bioprinting and product realization. He is the recipient of the Elginkan Foundation Science and Technology Award, Turkish Heart Association Award, “Most cited Author in Computer Aided Design” Award from Elsevier, UB STOR Inventor Award and UB Reifler Award. He has published more than 80 scientific publications (journal articles, book chapters and conference articles). Prof. Koç’s research works have been supported by major national, international research agencies and organizations and companies such as the Scientific and Technological Research Council of Turkey (TÜBİTAK), the Turkish Ministry of Development, the European Research Council FP7, U.S. Army Medical Research and companies. Prof. Koç is an Associate Editor and a member of editorial boards of several journals in his research area. His recent research work related to 3D Organ Bioprinting was highlighted at several international and national TV channels (BBC, CNN Turk etc.) Newspapers and blogs.
Dear Colleagues,
Three dimensional (3D) Bioprinting is used for 3D printing of cells alone or with a combination of biomaterials, active molecules to fabricate tissue/organ substitutes. Tissue or organ substitutes needs to be first digitally modeled by biomimicking the targeted tissue/organs. Bioinks containing live cells, biomaterials and active molecules should also developed and optimized for not only targeted tissue/ organ but also for printability. To control the bioprinters, the instructions and printing paths are then calculated using computational methods. The prepared bioinks are then loaded on to a bioprinter. 3D bioprinters needs to be specifically developed for printing bioinks with no or minimum damages to cells. After bioprinting tissue or organ substitutes, they need to be maturated using bioreactors. The bioprinted tissue/organ substitutes can be used in not only tissue/organ engineering, regenerative medicine but also in drug discovery. This Research Topic will cover recent advances in multifunctional bioprinting for tissue/organ engineering.
A 3D bioprinted alginate-MgP scaffold for superior regeneration of calvarial bone defects in a rat model